UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Nonpharmacological Lipoprotein Apheresis Reduces Arterial Inflammation in Familial Hypercholesterolemia

Journal of the American College of Cardiology, 2014-10, Vol.64 (14), p.1418-1426

2014

Link zum Volltext

Verfügbarkeit prüfen

Effect of Mipomersen, an Apolipoprotein B Synthesis Inhibitor, on Low-Density Lipoprotein Cholesterol in Patients With Familial Hypercholesterolemia

The American journal of cardiology, 2010-05, Vol.105 (10), p.1413-1419

2010

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Mipomersen, an Antisense Inhibitor of Apolipoprotein B, in Hypercholesterolemic Subjects Receiving Stable Statin Therapy

Journal of the American College of Cardiology, 2010-04, Vol.55 (15), p.1611-1618

2010

Link zum Volltext

Verfügbarkeit prüfen

Oxidation-Specific Biomarkers, Lipoprotein(a), and Risk of Fatal and Nonfatal Coronary Events

Journal of the American College of Cardiology, 2010-09, Vol.56 (12), p.946-955

2010

Link zum Volltext

Verfügbarkeit prüfen

Plasma Triglycerides and Cardiovascular Events in the Treating to New Targets and Incremental Decrease in End-Points Through Aggressive Lipid Lowering Trials of Statins in Patients With Coronary Artery Disease

The American journal of cardiology, 2009-08, Vol.104 (4), p.459-463

2009

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Rosuvastatin Therapy for Children With Familial Hypercholesterolemia

Journal of the American College of Cardiology, 2010-03, Vol.55 (11), p.1121-1126

2010

Link zum Volltext

Verfügbarkeit prüfen

Lipoprotein(a) Improves Cardiovascular Risk Prediction Based on Established Risk Algorithms

Journal of the American College of Cardiology, 2017-03, Vol.69 (11), p.1513-1515

2017

Link zum Volltext

Verfügbarkeit prüfen

Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: The EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial

Journal of clinical lipidology, 2014, Vol.8 (1), p.94-106

2014

Link zum Volltext

Verfügbarkeit prüfen

Beyond Low-Density Lipoprotein Cholesterol

Journal of the American College of Cardiology, 2009-12, Vol.55 (1), p.35-41

2009

Link zum Volltext

Verfügbarkeit prüfen

Obesity and dyslipidemia

The Medical clinics of North America, 2011-09, Vol.95 (5), p.893

2011

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Coadministration of Ezetimibe and Simvastatin in Adolescents With Heterozygous Familial Hypercholesterolemia

Journal of the American College of Cardiology, 2008-10, Vol.52 (17), p.1421-1429

2008

Link zum Volltext

Verfügbarkeit prüfen

Intensive Lipid Lowering With Atorvastatin in Patients With Coronary Heart Disease and Chronic Kidney Disease

Journal of the American College of Cardiology, 2008-04, Vol.51 (15), p.1448-1454

2008

Link zum Volltext

Verfügbarkeit prüfen

Safety and Tolerability of Dalcetrapib

The American journal of cardiology, 2009-07, Vol.104 (1), p.82-91

2009

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Pitavastatin in Children and Adolescents at High Future Cardiovascular Risk

The Journal of pediatrics, 2015-08, Vol.167 (2), p.338-343.e5

2015

Link zum Volltext

Verfügbarkeit prüfen

Statin Initiation During Childhood in Patients With Familial Hypercholesterolemia

Journal of the American College of Cardiology, 2016-02, Vol.67 (4), p.455-456

2016

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Ezetimibe Monotherapy in Children with Heterozygous Familial or Nonfamilial Hypercholesterolemia

The Journal of pediatrics, 2015-06, Vol.166 (6), p.1377-1384.e3

2015

Link zum Volltext

Verfügbarkeit prüfen

Intervention to Improve Adherence to Lipid-Lowering Medication and Lipid-Levels in Patients With an Increased Cardiovascular Risk

The American journal of cardiology, 2012-09, Vol.110 (5), p.666-672

2012

Link zum Volltext

Verfügbarkeit prüfen

Risk of New-Onset Diabetes and Cardiovascular Risk Reduction From High-Dose Statin Therapy in Pre-Diabetics and Non – Pre-Diabetics

Journal of the American College of Cardiology, 2015-02, Vol.65 (4), p.402-404

2015

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 monoclonal antibody alirocumab vs placebo in patients with heterozygous familial hypercholesterolemia

Journal of clinical lipidology, 2017-01, Vol.11 (1), p.195-203.e4

2017

Link zum Volltext

Verfügbarkeit prüfen

Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: A 12-week, multicenter, randomized, double-blind, controlled trial

Clinical therapeutics, 2010-04, Vol.32 (4), p.615-625

2010

Link zum Volltext

Verfügbarkeit prüfen

Intensive Lipid-Lowering With Atorvastatin for Secondary Prevention in Patients After Coronary Artery Bypass Surgery

Journal of the American College of Cardiology, 2008-05, Vol.51 (20), p.1938-1943

2008

Link zum Volltext

Verfügbarkeit prüfen

Emerging Cardiovascular Disease Biomarkers and Incident Diabetes Mellitus Risk in Statin-Treated Patients with Coronary Artery Disease (From the Treating to New Targets [TNT] Study)

The American journal of cardiology, 2016-08, Vol.118 (4), p.494-498

2016

Link zum Volltext

Verfügbarkeit prüfen

Follow-Up of Children Diagnosed with Familial Hypercholesterolemia in a National Genetic Screening Program

The Journal of pediatrics, 2012-07, Vol.161 (1), p.99-103

2012

Link zum Volltext

Verfügbarkeit prüfen

Adiponectin and Risk of Coronary Heart Disease in Apparently Healthy Men and Women (from the EPIC-Norfolk Prospective Population Study)

The American journal of cardiology, 2011-08, Vol.108 (3), p.367-373

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 67

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(65)

Publikationsform

Artikel
(67)

Sprache

Englisch
(67)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Nonpharmacological Lipoprotein Apheresis Reduces Arterial Inflammation in Familial Hypercholesterolemia

Effect of Mipomersen, an Apolipoprotein B Synthesis Inhibitor, on Low-Density Lipoprotein Cholesterol in Patients With Familial Hypercholesterolemia

Efficacy and Safety of Mipomersen, an Antisense Inhibitor of Apolipoprotein B, in Hypercholesterolemic Subjects Receiving Stable Statin Therapy

Oxidation-Specific Biomarkers, Lipoprotein(a), and Risk of Fatal and Nonfatal Coronary Events

Plasma Triglycerides and Cardiovascular Events in the Treating to New Targets and Incremental Decrease in End-Points Through Aggressive Lipid Lowering Trials of Statins in Patients With Coronary Artery Disease

Efficacy and Safety of Rosuvastatin Therapy for Children With Familial Hypercholesterolemia

Lipoprotein(a) Improves Cardiovascular Risk Prediction Based on Established Risk Algorithms

Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: The EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial

Beyond Low-Density Lipoprotein Cholesterol

Obesity and dyslipidemia

Efficacy and Safety of Coadministration of Ezetimibe and Simvastatin in Adolescents With Heterozygous Familial Hypercholesterolemia

Intensive Lipid Lowering With Atorvastatin in Patients With Coronary Heart Disease and Chronic Kidney Disease

Safety and Tolerability of Dalcetrapib

Efficacy and Safety of Pitavastatin in Children and Adolescents at High Future Cardiovascular Risk

Statin Initiation During Childhood in Patients With Familial Hypercholesterolemia

Efficacy and Safety of Ezetimibe Monotherapy in Children with Heterozygous Familial or Nonfamilial Hypercholesterolemia

Intervention to Improve Adherence to Lipid-Lowering Medication and Lipid-Levels in Patients With an Increased Cardiovascular Risk

Risk of New-Onset Diabetes and Cardiovascular Risk Reduction From High-Dose Statin Therapy in Pre-Diabetics and Non – Pre-Diabetics

Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation

Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 monoclonal antibody alirocumab vs placebo in patients with heterozygous familial hypercholesterolemia

Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: A 12-week, multicenter, randomized, double-blind, controlled trial

Intensive Lipid-Lowering With Atorvastatin for Secondary Prevention in Patients After Coronary Artery Bypass Surgery

Emerging Cardiovascular Disease Biomarkers and Incident Diabetes Mellitus Risk in Statin-Treated Patients with Coronary Artery Disease (From the Treating to New Targets [TNT] Study)

Follow-Up of Children Diagnosed with Familial Hypercholesterolemia in a National Genetic Screening Program

Adiponectin and Risk of Coronary Heart Disease in Apparently Healthy Men and Women (from the EPIC-Norfolk Prospective Population Study)

Suchergebnisse filtern